2022 Hyundai Venue SEL
1.6 L • 4 • FWD • AT
KMHRC8A34NU187955
Sales history: 2
Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
2 records
Drive
1.6 L • 4 • FWD • AT
Odometer
34,966 mi ≈ 56,272 km
Primary damage
Front end
Secondary damage
Side
Docs
Salvage
Extra
Auction
VIN
KMHRC8A34NU187955
Lot number
86426744
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Somerville, NJ
Description
Fuel type
Gasoline
Body color
Blue
Body type
Wagon
Trim
SEL
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2022 Hyundai Venue SEL • 1.6 L • 4 cyl • FWD • Automatic • Copart Lot: 86426744 • VIN: KMHRC8A34NU187955
Find out more about this 2022 Hyundai Venue SEL, available at the Copart salvage car auction as lot 86426744 in Somerville, NJ. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 34,966 mi. This Blue Hyundai Venue Wagon is equipped with Gasoline 1.6 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KMHRC8A34NU187955 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
